『JACC Specialty Journals』のカバーアート

JACC Specialty Journals

JACC Specialty Journals

著者： American College of Cardiology
無料で聴く

In this podcast series, editors-in-chief from the JACC family of specialty journals provide highlights and summarize key findings for select issues. Published by the American College of Cardiology, the JACC Journals publish peer-reviewed articles on all aspects of cardiovascular disease, including original clinical studies, translational investigations with clear clinical relevance, state-of-the art papers, and review articles. They are top ranked for impact factor and their manuscripts are among the most covered by media outlets, most talked about on social media, and most read online.American College of Cardiology Foundation. All rights reserved. 生物科学 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • August 2026 Full Issue Summary | JACC: CardioOncology

    August 2026 Full Issue Summary | JACC: CardioOncology
    2026/06/16

    Audio summary of JACC: CardioOncology's June issue.
    続きを読む 一部表示
    21 分
  • A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral Anticoagulants | JACC: CardioOncology

    A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral Anticoagulants | JACC: CardioOncology
    2026/06/16

    This podcast by Dr. Larissa Araújo de Lucena discusses the development of the ONCO‑DOAC BLEED score for predicting major bleeding in patients with cancer‑associated venous thromboembolism (VTE) receiving direct oral anticoagulants. The findings support a more personalized, risk‑based approach to anticoagulation in cardio‑oncology, integrating cancer type, comorbidities, and clinical factors while highlighting the need for broader validation.
    続きを読む 一部表示
    3 分
  • Differential Transthyretin Stabilization in Patients With Wild-Type and Variant Transthyretin Amyloidosis | JACC: CardioOncology

    Differential Transthyretin Stabilization in Patients With Wild-Type and Variant Transthyretin Amyloidosis | JACC: CardioOncology
    2026/06/16

    This podcast by Dr. Ron Witteles reviews new data on transthyretin amyloid cardiomyopathy (ATTR‑CM), highlighting differences in transthyretin stabilization between acoramidis and tafamidis across wild-type and variant disease. The discussion underscores the clinical importance of TTR stabilization, emerging biomarkers such as serum transthyretin, and the expanding therapeutic landscape in cardiac amyloidosis.
    続きを読む 一部表示
    6 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません